Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2008
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
08/19/2008US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody
08/19/2008US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
08/19/2008US7413850 Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis
08/19/2008US7413743 Active immunization using a siderophore receptor protein
08/19/2008US7413741 HCV E1 comprising specific disulfide bridges
08/19/2008CA2621616A1 Topical gatifloxacin formulations
08/19/2008CA2578891A1 Medicaments for fungal infections
08/19/2008CA2468708C Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs
08/19/2008CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/19/2008CA2434906C Use of an adenosine a3 receptor agonist for inhibition of viral replication
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2376803C Topical anti-microbial compositions
08/19/2008CA2219656C Antibacterial cephalosporins
08/19/2008CA2151801C 3'-modified oligonucleotide derivatives
08/14/2008WO2008098143A2 Antimicrobial compounds and methods of use
08/14/2008WO2008097796A1 Indolobenzazepine derivatives for the treatment of hepatitis c
08/14/2008WO2008097364A2 Use of oritavancin for prevention and treatment of anthrax
08/14/2008WO2008097317A1 Solvating system and sealant for medical use
08/14/2008WO2008097133A1 Medicinal agent for treating infectious diseases of domestic animals including diseases of viral etiology
08/14/2008WO2008097132A1 Medicinal agent for treating bird flu
08/14/2008WO2008097112A1 Amidinoanthracycline antibiotics for use in the treatment of viral infections
08/14/2008WO2008097109A1 Tonic and food supplement comprising aloe vera and honey
08/14/2008WO2008097103A1 Feed composition and uses thereof
08/14/2008WO2008096831A1 Therapeutic agent for cancer
08/14/2008WO2008096816A1 Angiogenesis inducer and polypeptide for use in the angiogenesis inducer
08/14/2008WO2008096814A1 Novel polypeptide and antibacterial agent comprising the same as active ingredient
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/14/2008WO2008096690A1 Polyethylene glycol derivative
08/14/2008WO2008096242A1 Antibodies specific for varicella zoster virus
08/14/2008WO2008096002A1 Hcv inhibiting macrocyclic phosphonates and amidophosphates
08/14/2008WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008WO2008095993A1 Novel nucleoside analogs for treatment of viral infections
08/14/2008WO2008095964A1 Crystalline form of moxifloxacin base
08/14/2008WO2008095479A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament
08/14/2008WO2008095429A1 A glycoprotein for treating chronic obstructive pulmonary diseases
08/14/2008WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof
08/14/2008WO2008095312A1 Use of high dose concentrations of gaseous nitric oxide
08/14/2008WO2008095276A1 Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease
08/14/2008WO2008069069A8 Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same
08/14/2008WO2008049855A3 7-azaindole derivatives as c-met kinase inhibitors
08/14/2008WO2008044054A3 Hydroxy-substituted benzoic acid amide compounds for use in therapy
08/14/2008WO2008041176A3 Process for the preparation of form i and form ii of ritonavir
08/14/2008WO2008038136A3 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
08/14/2008US20080195033 Method of Delivery of Therapeutic Metal Ions, Alloys and Salts
08/14/2008US20080194661 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol
08/14/2008US20080194640 Optically Active Tetrahydronaphthalene Derivative
08/14/2008US20080194619 Viricide against retrovirus infection; antiproliferative agents; 4-aminophenyl(1-azabicyclo92.2.2)ocy-4-yl)methanone
08/14/2008US20080194611 Modulation of Cell Barrier Dysfunction
08/14/2008US20080194607 Modulation of pathogenicity
08/14/2008US20080194601 Intermittent administering over a long time; by injection; using (4-((4-((2-cyanoethenyl)-2,3-dimethylphenyl )amino)2-pyrimidyl)amino)benzonitrile
08/14/2008US20080194588 Modulation of pathogcnicity
08/14/2008US20080194583 Tubulin Inhibitors
08/14/2008US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases
08/14/2008US20080194547 6-{[(3-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.1.0]hex-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
08/14/2008US20080194545 Antimicrobial compositions and methods of use
08/14/2008US20080194524 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
08/14/2008US20080194523 Diethyl[2-({[7-[(4-fluorophenyl)methyl]-4-hydroxy-3-({[2-(methyloxy)ethyl]amino}carbonyl)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetyl}amino)ethyl]phosphonate; alone or with a second enzyme inhibitor
08/14/2008US20080194518 Antimicrobial Compositions
08/14/2008US20080194517 Equine or canine immunomodulating composition and treatment method
08/14/2008US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
08/14/2008US20080194505 Point mutations; antibodies; fusion proteins
08/14/2008US20080194504 Rna-Mediated Interference to Control Disease in Terrestrial and Aquaculture Animals
08/14/2008US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug
08/14/2008US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics
08/14/2008US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA)
08/14/2008US20080193563 Harnessing wnt signaling to restrict hiv replication
08/14/2008US20080193553 Using plant extracts; sexual disorders; gastrointestinal disorders; cardiovascular disorders; remove toxins from body; therapy for skin disorders
08/14/2008US20080193532 Antibiotic, colloidal silicon dioxide, povidone, silicified microcrystalline cellulose, croscarmellose sodium, magnesium stearate and a coating, Cmax is reached in less than five hours; tuberculosis
08/14/2008US20080193508 Local anti-infective agent for treatment of nail fungal infections
08/14/2008US20080193486 Live, Oral Vaccine for Protection Against Shigella Dysenteriae Serotype 1
08/14/2008US20080193485 Dairy products; vaccines; packages
08/14/2008US20080193480 Infectious Bursal Disease Virus antigenic isolates and vaccines
08/14/2008US20080193478 Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus
08/14/2008US20080193477 Vaccination Against Dengue Virus Infection
08/14/2008US20080193476 Haemophilus influenzae type b (Hib) saccharide conjugates; serotypes; vaccine kits
08/14/2008US20080193471 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
08/14/2008US20080193468 Method for Stimulating the Immune Response of Newborns
08/14/2008US20080193463 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier
08/14/2008US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
08/14/2008US20080193433 Water free of pathogens, pyrogens, heavy metals, and viruses, sprouted grain comprising digestive enzymes and undenatured whey protein; glutathione, triozyme; cancer, hepatitis and human immunodeficiency virus
08/14/2008US20080193422 Separating T cells from specimen and cultivating in vitro with culture broth containing cytokines, interferons, tumor necrosis factor and interleukins; preventing or treating infectious diseases caused by salmonella
08/14/2008US20080193415 HSA-free formulations of interferon-beta
08/14/2008US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases
08/14/2008US20080193413 Anti-Infective Agents
08/14/2008US20080193411 Anti-viral Compounds
08/14/2008US20080193410 Treating warts or verrucae that are induced by papillomavirus; killed mumps virus, candida or trichophyton extract; cytokines or colony stimulating factor
08/14/2008DE202007015195U1 Korianderöl-Fraktionen enthaltende Zubereitungen und deren Verwendung zur Herstellung eines Arzneimittels oder kosmetischen Mittels Coriander oil fractions containing preparations and their use for the manufacture of a medicament or cosmetic agent
08/14/2008DE102007006761A1 Teilneutralisierte Wirkstoffe enthaltende Polymerformmassen Neutralized active ingredients containing polymer molding compounds
08/14/2008CA2677371A1 Antibodies specific for varicella zoster virus
08/14/2008CA2677244A1 Medicinal agent for treating of avian flu
08/14/2008CA2677236A1 Feed composition for salmonids and uses thereof
08/14/2008CA2677015A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008CA2676422A1 Oxabicycloheptane and oxabicycloheptene phosphatase inhibitors, their preparation and use
08/14/2008CA2676081A1 Solvating system and sealant for medical use
08/14/2008CA2675462A1 Novel nucleoside analogs for treatment of viral infections
08/14/2008CA2674014A1 Use of riluzole and derivatives thereof for producing new drugs
08/14/2008CA2664444A1 Use of oritavancin for prevention and treatment of anthrax
08/13/2008EP1956078A2 Liver engrafting cells, assays, and uses thereof
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1798